{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-229630","form_type":"8-K","ticker":"XAGE","cik":"0001842939","company_name":"Longevity Health Holdings, Inc.","filed_at":"2023-09-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.678670+00:00","generated_at":"2026-06-10T23:35:22.966775+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Carmell announces CEO change, board restructuring, and post-merger savings focus on aesthetics","bullets":["CEO Randy Hubbell resigns effective Aug 31, 2023; Rajiv Shukla (Exec Chair) appointed Chairman & CEO.","Four directors and four other execs depart as part of Axolotl Biologix integration; no disagreement cited.","$8M milestone payment to Axolotl rescheduled to Aug 31, 2024; projected annual savings of ~$3M from terminations.","Focus narrowed to aesthetics programs (skin rejuvenation, dental bone healing) with shorter path to commercialization."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-229630","json":"https://secwatch.observer/filing/0001193125-23-229630.json","markdown":"https://secwatch.observer/filing/0001193125-23-229630.md","text":"https://secwatch.observer/filing/0001193125-23-229630.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1842939/000119312523229630/0001193125-23-229630-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1842939/000119312523229630/d512811d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T23:35:22.966775+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"037f651a14","claim":"William Newlin resigned as Director at Longevity Health Holdings, Inc..","evidence_excerpt":"William Newlin, Steve Bariahtaris, Jaime Garza and Radolph W. Hubbell (collectively, the “Former Directors”) have each resigned from their respective position as a director of Carmell Corporation (the “Company”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1842939/000119312523229630/0001193125-23-229630-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"278d680d88","claim":"James Hart resigned as Chief Medical Officer at Longevity Health Holdings, Inc..","evidence_excerpt":"As of the Effective Date, the following executive officers of the Company have voluntarily resigned from their positions with the Company (collectively, the “Former Officers”). Name Position Randolph W. Hubbell Chief Executive Officer and President James Hart, M.D. Chief Medical Officer Donna Godward Chief Quality Officer Janet Vargo, Ph.D. Vice President Clinical Services","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1842939/000119312523229630/0001193125-23-229630-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Medical Officer"}],"fact_type":"executive_change"},{"claim_id":"4f38e61a6e","claim":"Donna Godward resigned as Chief Quality Officer at Longevity Health Holdings, Inc..","evidence_excerpt":"As of the Effective Date, the following executive officers of the Company have voluntarily resigned from their positions with the Company (collectively, the “Former Officers”). Name Position Randolph W. Hubbell Chief Executive Officer and President James Hart, M.D. Chief Medical Officer Donna Godward Chief Quality Officer Janet Vargo, Ph.D. Vice President Clinical Services","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1842939/000119312523229630/0001193125-23-229630-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Quality Officer"}],"fact_type":"executive_change"},{"claim_id":"6825aba966","claim":"Janet Vargo resigned as Vice President Clinical Services at Longevity Health Holdings, Inc..","evidence_excerpt":"As of the Effective Date, the following executive officers of the Company have voluntarily resigned from their positions with the Company (collectively, the “Former Officers”). Name Position Randolph W. Hubbell Chief Executive Officer and President James Hart, M.D. Chief Medical Officer Donna Godward Chief Quality Officer Janet Vargo, Ph.D. Vice President Clinical Services","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1842939/000119312523229630/0001193125-23-229630-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Vice President Clinical Services"}],"fact_type":"executive_change"},{"claim_id":"6c2ea428dd","claim":"Randolph W. Hubbell resigned as Chief Executive Officer and President at Longevity Health Holdings, Inc..","evidence_excerpt":"As of the Effective Date, the following executive officers of the Company have voluntarily resigned from their positions with the Company (collectively, the “Former Officers”). Name Position Randolph W. Hubbell Chief Executive Officer and President James Hart, M.D. Chief Medical Officer Donna Godward Chief Quality Officer Janet Vargo, Ph.D. Vice President Clinical Services","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1842939/000119312523229630/0001193125-23-229630-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Executive Officer and President"}],"fact_type":"executive_change"},{"claim_id":"b4da0a2269","claim":"Steve Bariahtaris resigned as Director at Longevity Health Holdings, Inc..","evidence_excerpt":"William Newlin, Steve Bariahtaris, Jaime Garza and Radolph W. Hubbell (collectively, the “Former Directors”) have each resigned from their respective position as a director of Carmell Corporation (the “Company”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1842939/000119312523229630/0001193125-23-229630-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"b6e3803f2b","claim":"Rajiv Shukla was appointed as Chief Executive Officer at Longevity Health Holdings, Inc..","evidence_excerpt":"As of the Effective Date, Rajiv Shukla, the Company’s current Executive Chairman, has been appointed as the Chief Executive Officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1842939/000119312523229630/0001193125-23-229630-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"eece90c52e","claim":"Jaime Garza resigned as Director at Longevity Health Holdings, Inc..","evidence_excerpt":"William Newlin, Steve Bariahtaris, Jaime Garza and Radolph W. Hubbell (collectively, the “Former Directors”) have each resigned from their respective position as a director of Carmell Corporation (the “Company”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1842939/000119312523229630/0001193125-23-229630-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}